Almirall’s scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

Mosaic becomes the exclusive provider of antibody discovery services using AbTherx's Atlas™ Full Human Diversity MouseStreamlined milestone- and royalty-free access with flexible engagement optionsEnd ...

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary ...

OncoZenge AB Enters into Collaboration with UCLA for Patient Engagement Study on BupiZenge™OncoZenge AB (publ) (“OncoZenge” or “the Company”), a pharmaceutical company developing an innovative ...

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech ...

Achieved expedited enrollment completion of first two Cohorts in Phase 1/2 Audiogene clinical trial evaluating SENS-501, the Company’s gene therapy candidate being developed to treat a specific form ...

Strengthen the PFS CMO business through a long-term partnership with global syringe leader BDExpand the global customer ...

Company Announces Second Closing of $67 Million Series A with New Investment by 8VCCAMBRIDGE, Mass.--(BUSINESS ...

Located near Tampa, 30,000 sq. ft. facility in Manatee County’s City of Palmetto will house state-of-the-art manufacturing ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

EAACI Prize recognizes the clinical impact of PRT120 and findings from the PPOIT-003LT study, which showed significant ...